Targeted Nano-formulations for Treatment of MRSA: A multicomponent platform for nano-formulated treatment of resistant microbial infections

Informations projet

LeadtoTreat

N° de convention de subvention: 101046941

DOI 10.3030/101046941

Date de signature de la CE 16 Mars 2022

Date de début 1 Mars 2022

Date de fin 28 Février 2026

Financé au titre de

• The European Innovation Council (EIC)

Coût total € 2 665 565,00

Contribution de l’UE € 2 665 564,75

Coordonné par

SINTEF AS
Norway

Livrables

Websites, patent fillings, videos etc. (1)

Public website and communication toolkit

Public website and communication toolkit prepared including design of logo

Documents, reports (2)

Updated Data Management Plan after RP1

Updated Data Management Plan after first reporting period

Data Management Plan

First version of the Data Management Plan